Search

Your search keyword '"Pavelka, K"' showing total 143 results

Search Constraints

Start Over You searched for: Author "Pavelka, K" Remove constraint Author: "Pavelka, K" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
143 results on '"Pavelka, K"'

Search Results

2. Circulating miRNAs in hand osteoarthritis

3. AB1144 THE ROLE OF SYSTEMIC S100A4 LEVELS IN SCLERODERMA AS A PREDICTOR OF TREATMENT RESPONSE AND EARLY PROGRESSION

4. OP0092 INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO bDMARDs: FINDINGS FROM AN INTERNATIONAL COLLABORATION OF REGISTERS (THE “JAK-POT” STUDY)

5. AB0964 EFFICACY AND DRUG SURVIVAL OF IXEKIZUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS FROM THE CZECH BIOLOGICS REGISTRY ATTRA: IMPACT OF PRIOR SECUKINUMAB EXPOSURE

6. AB1207 RITUXIMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS NON-RESPONSIVE TO CsDMARDs – PRELIMINARY RESULTS OF A PROSPECTIVE, OBSERVATIONAL, MONOCENTRIC STUDY

7. AB1227 SUBCLINCAL ATHEROSCLEROSIS AND CARDIOVASCULAR RISK IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THE GENERAL POPULATION

8. OP0137 CHALLENGING THE DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: COMPARATIVE ANALYSIS OF CLINICAL EFFICACY AND DRUG RETENTION OF SUBSEQUENT BIOLOGIC AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS

9. AB1482 MENTAL DISORDERS AND HELP-SEEKING IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AXIAL SPONDYLOARTHRITIS: RESULTS FROM A TERTIARY CENTRE CROSS-SECTIONAL STUDY

10. OP0034 DIFFERENTIAL JOINT-LEVEL RESPONSES TO TNF INHIBITORS IN PSORIATIC ARTHRITIS: A COLLABORATIVE EUROPEAN OBSERVATIONAL COHORT STUDY

11. AB1160 IL-40 ELEVATION IN SYSTEMIC SCLEROSIS: UNRAVELLING A LINK TO DISEASE ACTIVITY, GASTROINTESTINAL INVOLVEMENT, IMMUNE REGULATION AND FIBROTIC PROCESSES

15. POS0344 BASDAI CUT-OFFS FOR DISEASE ACTIVITY CORRESPONDING TO ASDAS-ESR CUT-OFFS IN AXIAL SPONDYLARTHRITIS – RESULTS FROM THE EUROSPA COLLABORATION

16. POS0656 DOES RADIOGRAPHIC STATUS IMPACT SECUKINUMAB EFFECTIVENESS IN EUROPEAN AXIAL SPONDYLOARTHRITIS PATIENTS TREATED IN ROUTINE CARE?

17. OP0076 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE NON-PHARMACOLOGICAL CORE MANAGEMENT OF HIP AND KNEE OSTEOARTHRITIS

18. POS1549 BETTER DRUG SURVIVAL ON MONOCLONAL ANTIBODIES COMPARED TO ETANERCEPT IN FIRST LINE ANTI-TNF THERAPY IN PATIENTS WITH PSORIATIC ARTHRITIS MAY BE DUE TO DIFFERENTIAL THERAPEUTIC RESPONSE IN SKIN INVOLVEMENT: A PROPENSITY SCORE-MATCHED ANALYSIS FROM THE NATIONWIDE CZECH ATTRA REGISTRY

20. POS0433 RELATIONSHIP BETWEEN MIRNA-1-3P, INTERLEUKIN-17 AND TUMOR NECROSIS FACTOR IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS

21. POS0439 SCREENING FOR PLASMA BIOMARKERS PREDICTING RADIOGRAPHIC PROGRESSION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: A PRELIMINARY STUDY

23. POS1226 CARDIOVASCULAR RISK IN PATIENTS WITH MYOSITIS COMPARED TO THE GENERAL POPULATION

25. OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)

26. POS0249 SEX DIFFERENCES IN PATIENT-REPORTED OUTCOMES IN AXIAL SPONDYLOARTHRITIS PATIENTS TREATED WITH TUMOR NECROSIS FACTOR INHIBITORS: RESULTS FROM A MULTINATIONAL OBSERVATIONAL COHORT STUDY

27. MODERN METHODS OF DOCUMENTATION AND VISUALIZATION OF HISTORICAL MINES IN THE UNESCO MINING REGION IN THE ORE MOUNTAINS

28. DIFFERENT DATA JOINING AS A BASIC MODEL FOR HBIM – A CASE PROJECT ST. PATALEIMON IN SKOPJE

29. ANALYSIS OF POSSIBLE GEODETIC APPROACHES FOR 3D MODEL CREATION IN BIM

31. Corrigendum to 'Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration' [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081]

32. One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.

34. Prevalence and distribution of cartilage and bone damage at metacarpal head in healthy subjects

35. Comparison of cardiovascular risk in idiopathic inflammatory myopathy with general population – Preliminary data from a single-centre cross-sectional study

36. SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EUROSPA RESEARCH COLLABORATION NETWORK

37. CAN SINGLE IMPUTATION TECHNIQUES FOR BASDAI COMPONENTS RELIABLY CALCULATE THE COMPOSITE SCORE IN AXIAL SPONDYLOARTHRITIS PATIENTS?

39. OP0266 TREATMENT DISCONTINUATION DUE TO ADVERSE EVENTS AS AN OVERALL MEASURE OF TOLERANCE AND SAFETY OF JAK-INHIBITORS: AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-pot” STUDY).

42. POS0001 CAN SINGLE IMPUTATION TECHNIQUES FOR BASDAI COMPONENTS RELIABLY CALCULATE THE COMPOSITE SCORE IN AXIAL SPONDYLOARTHRITIS PATIENTS?

44. POS0077 SEX DIFFERENCES IN EFFECTIVENESS OF FIRST-LINE TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS; RESULTS FROM THIRTEEN COUNTRIES IN THE EuroSpA RESEARCH COLLABORATION NETWORK

45. OP0105 miRNOME PROFILE IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS

46. AB0678 Subclinical Atherosclerosis and Cardiovascular Risk in Myositis Patients and Healthy Controls: Preliminary Data From a Single-center Cross-sectional Study

48. European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response

Catalog

Books, media, physical & digital resources